Owlet Q4 Results Beat Estimates but Guidance Falls Short
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy OWLT?
Source: stocktwits
- Q4 Performance: Owlet reported an adjusted net loss per share of $0.03 for Q4 2025, beating analyst estimates of a $0.16 loss, indicating resilience despite a net loss of $9.2 million, slightly higher than the previous year's $9.1 million.
- Revenue Growth: The company achieved $26.6 million in revenue for Q4 2025, a 29.6% year-over-year increase driven by strong sales of the Dream product suite and Owlet360 subscription service, surpassing analyst expectations of $25.83 million, showcasing robust product demand.
- Disappointing Guidance: For Q1 2026, Owlet expects revenue between $20 million and $21 million, significantly below Wall Street's forecast of $26.2 million, raising concerns about the company's near-term growth prospects and potentially impacting investor confidence.
- Annual Outlook: Owlet anticipates full-year 2026 revenue in the range of $126 million to $130 million, reflecting a 19% to 23% growth over 2025, indicating long-term growth potential despite short-term guidance falling short of expectations, warranting close monitoring of market reactions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OWLT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OWLT
Wall Street analysts forecast OWLT stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 11.880
Low
13.00
Averages
17.33
High
20.00
Current: 11.880
Low
13.00
Averages
17.33
High
20.00
About OWLT
Owlet, Inc. operates as a digital parenting platform company. The Company offers FDA-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children. Its products include Owlet Dream Sock, an app to assist children with better sleep; Owlet Cam, a video streaming app to hear and see the baby from anywhere, and Owlet Monitor Duo. Its sock monitor offerings include Smart Sock, Dream Sock and BabySat. Its Cam offerings include Cam 1 and Cam 2. Combining Dream Sock or Owlet Smart Sock with Owlet Cam, this baby monitoring solution offers HD video, sleep insights, and health tracking to offer an extensive view into an infant's well-being. Its accessories product line includes the Owlet Sleeper, a wearable rayon blanket that encourages safe sleep, best for babies ages three-six months old, and an Owlet Sock Travel Case.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Owlet, Inc. Reports Record Growth in 2025 Earnings Call
- Significant Revenue Growth: Owlet reported Q4 2025 revenue of $26.6 million, a 29.6% year-over-year increase, reflecting strong performance across the Dream product suite and Owlet360 subscription service, indicating sustained growth potential in the baby monitoring market.
- Market Share Increase: The company's market share reached 41% in Q4 2025, up 24% from Q4 2024, marking a further consolidation of Owlet's leadership position in the baby monitoring device sector and enhancing future competitive advantages.
- Strategic Expansion Plans: Owlet plans to launch the Owlet OnCall telehealth platform in 2026 and expand global adoption of the Dream Sock, aiming to enhance customer lifetime value through innovative AI-driven features, further driving revenue growth.
- Optimistic Future Outlook: The company expects 2026 revenue to range between $126 million and $130 million, representing a 19% to 23% growth, with adjusted EBITDA projected at $3 million to $5 million, reflecting confidence in future growth despite tariff and geopolitical uncertainties.
See More
Owlet Q4 Results Beat Estimates but Guidance Falls Short
- Q4 Performance: Owlet reported an adjusted net loss per share of $0.03 for Q4 2025, beating analyst estimates of a $0.16 loss, indicating resilience despite a net loss of $9.2 million, slightly higher than the previous year's $9.1 million.
- Revenue Growth: The company achieved $26.6 million in revenue for Q4 2025, a 29.6% year-over-year increase driven by strong sales of the Dream product suite and Owlet360 subscription service, surpassing analyst expectations of $25.83 million, showcasing robust product demand.
- Disappointing Guidance: For Q1 2026, Owlet expects revenue between $20 million and $21 million, significantly below Wall Street's forecast of $26.2 million, raising concerns about the company's near-term growth prospects and potentially impacting investor confidence.
- Annual Outlook: Owlet anticipates full-year 2026 revenue in the range of $126 million to $130 million, reflecting a 19% to 23% growth over 2025, indicating long-term growth potential despite short-term guidance falling short of expectations, warranting close monitoring of market reactions.
See More
Owlet Q4 Earnings Beat Expectations, 2026 Outlook Positive
- Strong Earnings Report: Owlet's Q4 non-GAAP EPS of $0.03 exceeded expectations by $0.14, indicating a significant improvement in profitability and boosting market confidence in future performance.
- Significant Revenue Growth: Q4 revenue reached $26.6 million, representing a 29.8% year-over-year increase and surpassing market expectations by $0.59 million, demonstrating the company's competitive position and sustained product demand.
- 2026 Financial Outlook: For Q1 2026, revenue is expected to range between $20 million and $21 million, with gross margins of 50% to 52%, and an Adjusted EBITDA forecast of $(2.5) million to $(1.5) million, reflecting the company's investment strategy during its expansion phase.
- Annual Growth Projections: The full-year 2026 revenue is projected to be between $126 million and $130 million, indicating a 19% to 23% growth over 2025, with gross margins expected at 49% to 52%, showcasing the company's growth potential despite tariff cost impacts.
See More
Owlet Selects HCM as Public Relations Agency
- PR Agency Selection: Owlet has chosen Hannah Cranston Media as its public relations agency following a competitive review, leveraging HCM's expertise in health tech and consumer innovation to enhance brand visibility in cultural and industry conversations.
- International Market Expansion: Owlet has monitored over 2.5 million babies across 30+ countries and successfully launched its Dream Sock in Australia, New Zealand, and South Africa, with plans to expand into India, a market with approximately 23 million annual births, showcasing its international growth strategy.
- Enhanced Product Ecosystem: Owlet's Dream Sock is the only FDA-cleared smart baby monitor on the market, complemented by products like Dream Sight and Dream Duo, creating a robust ecosystem that meets parents' health monitoring needs and sets a new standard in pediatric wellness.
- Strategic Partnerships: Owlet has formed a strategic partnership with webAI to build personalized intelligence from its proprietary dataset, enhancing user experience, while also collaborating with durable medical equipment partners to expand insurance-supported access to its prescription pulse oximeter, BabySat.
See More
Owlet Partners with PromptCare to Expand Pediatric Monitoring Services
- Strategic Partnership: Owlet has formed a partnership with PromptCare to expand its clinical and durable medical equipment (DME) footprint across the U.S., enhancing access to its FDA-cleared BabySat pulse oximeter through established pediatric care pathways, thereby strengthening its market competitiveness.
- Industry Experience Synergy: With over 40 years of experience in pediatric respiratory care and operating from more than 25 locations, PromptCare's clinically trained workforce will support Owlet's product distribution, significantly increasing market penetration and brand recognition.
- Brand Legitimacy Enhancement: This collaboration will bolster Owlet's position within the pediatric DME channel, enhance its brand legitimacy in hospital-to-home care pathways, and create more referral opportunities for both organizations, driving sales growth.
- Incremental Shipment Expectations: As pilot programs expand, PromptCare is expected to contribute additional unit shipments for Owlet, further propelling the company's growth in the pediatric health monitoring device market.
See More
OWLET FORGES STRATEGIC DME ALLIANCE WITH PROMPTCARE TO BROADEN DISTRIBUTION OF BABYSAT® PEDIATRIC PULSE OXIMETER
Strategic Partnership Announcement: Owlet has announced a strategic partnership with PromptCare to enhance the distribution of pediatric pulse oximeters.
Expansion of Distribution: The collaboration aims to expand the availability of Owlet's BabySat® product, which is designed for monitoring infants' oxygen levels.
See More
Owlet, Inc. Reports Record Growth in 2025 Earnings Call
- Significant Revenue Growth: Owlet reported Q4 2025 revenue of $26.6 million, a 29.6% year-over-year increase, reflecting strong performance across the Dream product suite and Owlet360 subscription service, indicating sustained growth potential in the baby monitoring market.
- Market Share Increase: The company's market share reached 41% in Q4 2025, up 24% from Q4 2024, marking a further consolidation of Owlet's leadership position in the baby monitoring device sector and enhancing future competitive advantages.
- Strategic Expansion Plans: Owlet plans to launch the Owlet OnCall telehealth platform in 2026 and expand global adoption of the Dream Sock, aiming to enhance customer lifetime value through innovative AI-driven features, further driving revenue growth.
- Optimistic Future Outlook: The company expects 2026 revenue to range between $126 million and $130 million, representing a 19% to 23% growth, with adjusted EBITDA projected at $3 million to $5 million, reflecting confidence in future growth despite tariff and geopolitical uncertainties.
See More
Owlet Q4 Results Beat Estimates but Guidance Falls Short
- Q4 Performance: Owlet reported an adjusted net loss per share of $0.03 for Q4 2025, beating analyst estimates of a $0.16 loss, indicating resilience despite a net loss of $9.2 million, slightly higher than the previous year's $9.1 million.
- Revenue Growth: The company achieved $26.6 million in revenue for Q4 2025, a 29.6% year-over-year increase driven by strong sales of the Dream product suite and Owlet360 subscription service, surpassing analyst expectations of $25.83 million, showcasing robust product demand.
- Disappointing Guidance: For Q1 2026, Owlet expects revenue between $20 million and $21 million, significantly below Wall Street's forecast of $26.2 million, raising concerns about the company's near-term growth prospects and potentially impacting investor confidence.
- Annual Outlook: Owlet anticipates full-year 2026 revenue in the range of $126 million to $130 million, reflecting a 19% to 23% growth over 2025, indicating long-term growth potential despite short-term guidance falling short of expectations, warranting close monitoring of market reactions.
See More
Owlet Q4 Earnings Beat Expectations, 2026 Outlook Positive
- Strong Earnings Report: Owlet's Q4 non-GAAP EPS of $0.03 exceeded expectations by $0.14, indicating a significant improvement in profitability and boosting market confidence in future performance.
- Significant Revenue Growth: Q4 revenue reached $26.6 million, representing a 29.8% year-over-year increase and surpassing market expectations by $0.59 million, demonstrating the company's competitive position and sustained product demand.
- 2026 Financial Outlook: For Q1 2026, revenue is expected to range between $20 million and $21 million, with gross margins of 50% to 52%, and an Adjusted EBITDA forecast of $(2.5) million to $(1.5) million, reflecting the company's investment strategy during its expansion phase.
- Annual Growth Projections: The full-year 2026 revenue is projected to be between $126 million and $130 million, indicating a 19% to 23% growth over 2025, with gross margins expected at 49% to 52%, showcasing the company's growth potential despite tariff cost impacts.
See More
Owlet Selects HCM as Public Relations Agency
- PR Agency Selection: Owlet has chosen Hannah Cranston Media as its public relations agency following a competitive review, leveraging HCM's expertise in health tech and consumer innovation to enhance brand visibility in cultural and industry conversations.
- International Market Expansion: Owlet has monitored over 2.5 million babies across 30+ countries and successfully launched its Dream Sock in Australia, New Zealand, and South Africa, with plans to expand into India, a market with approximately 23 million annual births, showcasing its international growth strategy.
- Enhanced Product Ecosystem: Owlet's Dream Sock is the only FDA-cleared smart baby monitor on the market, complemented by products like Dream Sight and Dream Duo, creating a robust ecosystem that meets parents' health monitoring needs and sets a new standard in pediatric wellness.
- Strategic Partnerships: Owlet has formed a strategic partnership with webAI to build personalized intelligence from its proprietary dataset, enhancing user experience, while also collaborating with durable medical equipment partners to expand insurance-supported access to its prescription pulse oximeter, BabySat.
See More
Owlet Partners with PromptCare to Expand Pediatric Monitoring Services
- Strategic Partnership: Owlet has formed a partnership with PromptCare to expand its clinical and durable medical equipment (DME) footprint across the U.S., enhancing access to its FDA-cleared BabySat pulse oximeter through established pediatric care pathways, thereby strengthening its market competitiveness.
- Industry Experience Synergy: With over 40 years of experience in pediatric respiratory care and operating from more than 25 locations, PromptCare's clinically trained workforce will support Owlet's product distribution, significantly increasing market penetration and brand recognition.
- Brand Legitimacy Enhancement: This collaboration will bolster Owlet's position within the pediatric DME channel, enhance its brand legitimacy in hospital-to-home care pathways, and create more referral opportunities for both organizations, driving sales growth.
- Incremental Shipment Expectations: As pilot programs expand, PromptCare is expected to contribute additional unit shipments for Owlet, further propelling the company's growth in the pediatric health monitoring device market.
See More
OWLET FORGES STRATEGIC DME ALLIANCE WITH PROMPTCARE TO BROADEN DISTRIBUTION OF BABYSAT® PEDIATRIC PULSE OXIMETER
Strategic Partnership Announcement: Owlet has announced a strategic partnership with PromptCare to enhance the distribution of pediatric pulse oximeters.
Expansion of Distribution: The collaboration aims to expand the availability of Owlet's BabySat® product, which is designed for monitoring infants' oxygen levels.
See More
